MHRA announces EU exit no-deal legislative proposals
Innovators should be able to get products to the UK market as quickly and simply as possible, according to the Medicines and Healthcare products Regulatory Agency...
List view / Grid view
News
Blood pressure and heart medication recalled by MHRA in UK
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine...
Deloitte finds Pharma returns on R&D reach new low
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010...
Clinical trial to develop breath test for cancer launched
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
Canagliflozin may not be associated with fracture risk in diabetes patients
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
Correcting minority underrepresentation in MS clinical trials
Minority underrepresentation in clinical trials for drugs to treat MS has led to doctors being unable to make informed decisions when prescribing...
Tailor-made excipients, developed the Kolb way
Standard excipients can be sourced from various suppliers, but what if you need to customise an excipient to suit your needs?
Predictions of early responses in paediatric acute lymphoblastic leukaemia
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair...
Ensuring supplier and compounded drug quality
It is paramount that manufacturers and their suppliers ensure that the quality of compounded drugs are high, by preventing risks of contamination...
Data integrity and compliance with drug current good manufacturing practices
The FDA has provided guidance on data integrity and compliance; two areas extremely important for pharmaceutical businesses and manufacturers to adhere to...
Blood tests could lead to personalised cystic fibrosis treatment
A blood test could transform the way doctors treat people affected by cystic fibrosis, helping to personalise treatments to individual people...
Sprayable gel with CD47 blockers could be the future of drug delivery for cancer
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
Licences for manufacturers and wholesalers of medicines and ingredients
Updated public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended...
Tailored treatment for acute myeloid leukaemia
The screening of leukaemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for AML...
Ocrelizumab reccommended for relapsing remitting multiple sclerosis
Ocrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
